CRISPR’s Nobel Prize sent gene-editing stocks into overdrive
CRISPR’s Nobel Prize sent gene-editing stocks into overdrive
Biotech stocks continued to surge on Wednesday after two scientists responsible for gene-editing tool CRISPR received this year’s Nobel Prize for Chemistry. CRISPR-powered stocks Intellia Therapeutics (NTLA), Editas Medicine (EDIT), and Beam Therapeutics (BEA…
